Preoperative chemotherapy for colon cancer is getting closer

The Lancet Oncology

Volumn 13, Issue 11, 2012, Pages 1073-1074

  Cervantes, Andrés ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; FOLINIC ACID; K RAS PROTEIN; OXALIPLATIN; PANITUMUMAB;

ADD ON THERAPY; ADJUVANT THERAPY; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PATIENT CARE; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT DURATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; PREOPERATIVE PERIOD; RECTAL NEOPLASMS;

EID: 84868195425     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70389-3     Document Type: Letter

References (11)

1. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2010, 21(Suppl 5):v70-77.
2. André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009, 27:3109-3116.
3. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007, 25:2198-2204.
4. Haller DG, Tabernero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011, 29:1465-1471.
5. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012, FOxTROT Collaborative Group, published online September 24. http://dx.doi.org/10.1016/S1470-2045(12)70348-0.
6. Dighe S, Blake H, Koh MD, et al. Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg 2010, 97:1407-1415.
7. Huh JW, Jeong YY, Kim HR, Kim YJ Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer. Ann Oncol 2012, 23:1198-1206.
8. Dighe S, Purkayastha S, Swift I, et al. Diagnostic precision of CT in local staging of colon cancers: A meta-analysis. Clin Radiol 2010, 65:708-719.
9. West NP, Hohenberger W, Weber K, et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010, 28:272-278.
10. Alberts SR, Sargent DJ, Nair S, et al. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer. A randomized trial. JAMA 2012, 307:1383-1393.
11. Taïeb J, Tabernero J, Mini E, et al. Adjuvant FOLFOX4 +/- cetuximab in KRAS wild-type patients with resected stage III colon cancer results from the PETACC8 intergroup trial. Ann Oncol 2012, 23(suppl 4). abstr 0028.